Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.25M | -1.47M | -14.35M | -1.27M | -27.11M |
| Total Depreciation and Amortization | 286.00K | 856.00K | 2.00K | 1.00K | 2.00K |
| Total Amortization of Deferred Charges | -- | -568.00K | 286.00K | 282.00K | 277.00K |
| Total Other Non-Cash Items | -5.97M | 526.00K | 13.36M | 291.00K | 26.26M |
| Change in Net Operating Assets | 541.00K | 42.00K | 6.00K | 11.00K | -412.00K |
| Cash from Operations | 99.00K | -613.00K | -694.00K | -682.00K | -986.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 1.00K | 0.00 | 1.00K | 0.00 |
| Cash from Investing | 1.00K | 1.00K | 0.00 | 1.00K | 0.00 |
| Total Debt Issued | 184.00K | -- | -- | -- | 317.00K |
| Total Debt Repaid | -293.00K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.00K | -- | -- | -- | 317.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.00K | -612.00K | -694.00K | -681.00K | -669.00K |